Publications by authors named "Wujiang Lai"

Persistent human papillomavirus (HPV) infection is associated with multiple malignancies. Developing therapeutic vaccines to eliminate HPV-infected and malignant cells holds significant value. In this study, we introduced a lipid nanoparticle encapsulated mRNA vaccine expressing tHA-mE7-mE6.

View Article and Find Full Text PDF

Resistance to the chemotherapeutic agent cisplatin (DDP) is the primary reason for invalid chemotherapy of ovarian cancer. Given the complex mechanisms underlying chemo-resistance, the design of combination therapies based on blocking multiple mechanisms is a rationale to synergistically elevate therapeutic effect for effectively overcoming cancer chemo-resistance. Herein, we demonstrated a multifunctional nanoparticle (DDP-Ola@HR), which could simultaneously co-deliver DDP and Olaparib (Ola, DNA damage repair inhibitor) using targeted ligand cRGD peptide modified with heparin (HR) as nanocarrier, enabling the concurrent tackling of multiple resistance mechanisms to effectively inhibit the growth and metastasis of DDP-resistant ovarian cancer.

View Article and Find Full Text PDF

Immune cell infiltration and metabolic reprogramming may have great impact on the tumorigenesis and progression of malignancies. The interaction between these two factors in cervical cancer remains to be clarified. Here we constructed a gene set containing immune and metabolism related genes and we applied this gene set to molecular subtyping of cervical cancer.

View Article and Find Full Text PDF

Aberrant pro-inflammatory activation of Kupffer cells (KCs) is strongly involved in the pathogenesis of septic liver injury. Recent evidence indicates the crucial roles of excessive stimulator of interferon genes (STING) signaling activation during sepsis. However, the role of STING signaling in septic liver injury remains unclear.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Wujiang Lai"

  • - Wujiang Lai is focused on developing innovative therapeutic strategies for cancer treatment, specifically targeting HPV-related cancer through mRNA vaccines and overcoming chemoresistance in ovarian cancer using multifunctional nanoparticles.
  • - His recent studies explore the interaction between immune cell infiltration and metabolic reprogramming in cervical cancer, which may provide insights into tumorigenesis and prognosis.
  • - Lai also investigates the role of STING signaling in liver injury during sepsis, enhancing the understanding of inflammatory mechanisms involved in liver pathology.